S Unholzer1,2,3, A Rothmund4, E Haen5,4,6. 1. AG Klinische Pharmakologie, Poliklinik für Psychiatrie und Psychotherapie, Bezirksklinikum Regensburg, Universitätsstr. 84, 93053, Regensburg, Deutschland. sandra.unholzer@klinik.uni-regensburg.de. 2. Institut für Pharmakologie und Toxikologie, Universität Regensburg, Universitätsstraße 31, Regensburg, 93053, Deutschland. sandra.unholzer@klinik.uni-regensburg.de. 3. Institut AGATE gGmbH, Nelkenweg 10, Pentling, 93080, Deutschland. sandra.unholzer@klinik.uni-regensburg.de. 4. Institut für Pharmakologie und Toxikologie, Universität Regensburg, Universitätsstraße 31, Regensburg, 93053, Deutschland. 5. AG Klinische Pharmakologie, Poliklinik für Psychiatrie und Psychotherapie, Bezirksklinikum Regensburg, Universitätsstr. 84, 93053, Regensburg, Deutschland. 6. Institut AGATE gGmbH, Nelkenweg 10, Pentling, 93080, Deutschland.
Abstract
BACKGROUND: Many indications are discussed for vitamin D substitution, such as osteoporosis, autoimmune diseases, cancer and psychiatric diseases. Also discussed is the fact that the majority of the German population suffer from a vitamin D deficiency. OBJECTIVE: Review of the study results for these individual diseases and a critical analysis of the currently established therapeutic reference range, which defines a vitamin D deficiency. MATERIAL AND METHODS: A literature search was carried out in the statements of the German Society for Nutrition, in scientific publications and journals. RESULTS: The study results on prevention and therapy of various diseases with vitamin D show inconsistent results. Well-established indications are the prevention of rickets in babies and the supportive therapy for osteoporosis. The currently established reference range for the definition of a vitamin D deficiency came from studies where vitamin D deficiency was correlated to an increase in parathyroid hormone. Different laboratories use different methods for measurement of vitamin D levels. CONCLUSION: More studies are needed to clarify the role of vitamin D in the prevention and treatment of various diseases. Another problem is that different laboratories do not use the same measurement methods to determine vitamin D and the use of different methods leads to widely varying results which cannot be compared. Therefore, a standardization of the methods would be desirable.
BACKGROUND: Many indications are discussed for vitamin D substitution, such as osteoporosis, autoimmune diseases, cancer and psychiatric diseases. Also discussed is the fact that the majority of the German population suffer from a vitamin D deficiency. OBJECTIVE: Review of the study results for these individual diseases and a critical analysis of the currently established therapeutic reference range, which defines a vitamin D deficiency. MATERIAL AND METHODS: A literature search was carried out in the statements of the German Society for Nutrition, in scientific publications and journals. RESULTS: The study results on prevention and therapy of various diseases with vitamin D show inconsistent results. Well-established indications are the prevention of rickets in babies and the supportive therapy for osteoporosis. The currently established reference range for the definition of a vitamin D deficiency came from studies where vitamin D deficiency was correlated to an increase in parathyroid hormone. Different laboratories use different methods for measurement of vitamin D levels. CONCLUSION: More studies are needed to clarify the role of vitamin D in the prevention and treatment of various diseases. Another problem is that different laboratories do not use the same measurement methods to determine vitamin D and the use of different methods leads to widely varying results which cannot be compared. Therefore, a standardization of the methods would be desirable.
Entities:
Keywords:
Cholecalciferol; Hypertension; Prevention; Psychiatric diseases; Vitamin D deficiency
Authors: Andrea Z LaCroix; Jane Kotchen; Garnet Anderson; Robert Brzyski; Jane A Cauley; Steven R Cummings; Margery Gass; Karen C Johnson; Marcia Ko; Joseph Larson; JoAnn E Manson; Marcia L Stefanick; Jean Wactawski-Wende Journal: J Gerontol A Biol Sci Med Sci Date: 2009-02-16 Impact factor: 6.053
Authors: Joan M Lappe; Dianne Travers-Gustafson; K Michael Davies; Robert R Recker; Robert P Heaney Journal: Am J Clin Nutr Date: 2007-06 Impact factor: 7.045
Authors: Lucinda J Black; Peter Jacoby; Karina L Allen; Gina S Trapp; Prue H Hart; Susan M Byrne; Trevor A Mori; Lawrence J Beilin; Wendy H Oddy Journal: Aust N Z J Psychiatry Date: 2013-11-13 Impact factor: 5.744
Authors: H A Bischoff-Ferrari; B Dawson-Hughes; H B Staehelin; J E Orav; A E Stuck; R Theiler; J B Wong; A Egli; D P Kiel; J Henschkowski Journal: BMJ Date: 2009-10-01